GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio Vitos Pharma AB (OSTO:BIOVIT) » Definitions » Net Margin %

Bio Vitos Pharma AB (OSTO:BIOVIT) Net Margin % : -2,352.99% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bio Vitos Pharma AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Bio Vitos Pharma AB's Net Income for the three months ended in Mar. 2024 was kr-3.15 Mil. Bio Vitos Pharma AB's Revenue for the three months ended in Mar. 2024 was kr0.13 Mil. Therefore, Bio Vitos Pharma AB's net margin for the quarter that ended in Mar. 2024 was -2,352.99%.

The historical rank and industry rank for Bio Vitos Pharma AB's Net Margin % or its related term are showing as below:

OSTO:BIOVIT' s Net Margin % Range Over the Past 10 Years
Min: -53910   Med: -3810.42   Max: -428.12
Current: -428.12


OSTO:BIOVIT's Net Margin % is ranked worse than
87.93% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: -0.685 vs OSTO:BIOVIT: -428.12

Bio Vitos Pharma AB Net Margin % Historical Data

The historical data trend for Bio Vitos Pharma AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Vitos Pharma AB Net Margin % Chart

Bio Vitos Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3,810.42 -1,244.78 -1,128.79 -429.47

Bio Vitos Pharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -598.29 -76.88 -3,343.69 -619.90 -2,352.99

Competitive Comparison of Bio Vitos Pharma AB's Net Margin %

For the Medical Devices subindustry, Bio Vitos Pharma AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Vitos Pharma AB's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio Vitos Pharma AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bio Vitos Pharma AB's Net Margin % falls into.



Bio Vitos Pharma AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bio Vitos Pharma AB's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-12.867/2.996
=-429.47 %

Bio Vitos Pharma AB's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-3.153/0.134
=-2,352.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio Vitos Pharma AB  (OSTO:BIOVIT) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Bio Vitos Pharma AB Net Margin % Related Terms

Thank you for viewing the detailed overview of Bio Vitos Pharma AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio Vitos Pharma AB (OSTO:BIOVIT) Business Description

Traded in Other Exchanges
N/A
Address
Karlstads universitet, Biomedicin, Universitetsgatan 2, Karlstad, SWE, 651 88
Bio Vitos Pharma AB Formelry Hemcheck Sweden AB is a Sweden based medical technology company. It is developing a product addressing the issue of hemolyzed blood samples.

Bio Vitos Pharma AB (OSTO:BIOVIT) Headlines

No Headlines